Michael Flynn1, Margaret Jamison, Santanu Datta, Evan Myers. 1. Division of Gynecological Specialties, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA. michaelk_flynn@urmc.rochester.edu
Abstract
OBJECTIVE: The purpose of this study was to quantify the total direct cost to the US health care system for the management of uterine leiomyomas. STUDY DESIGN: We used Center for Disease Control heath care databases for estimates of inpatient care, ambulatory care, and outpatient care of leiomyomas. With International Classification of Diseases-9 codes for fibroid tumors and fibroid-related conditions, all fibroid-related care was identified in each database. Inpatient and ambulatory surgical cases were stratified by surgical procedure, and outpatient clinical cases were categorized by type of visit and health care provider. With the use of Medicare's RBRVU reimbursement rates for 2000 as a proxy for the cost of physician services and Medicare diagnostic-related group reimbursement as a proxy for facility costs, the total direct cost to the US health care system for the care of fibroid tumors was estimated. RESULTS: Total direct cost to treat uterine fibroid tumors was estimated at 2,151,484,847 dollars. Most of the cost was due to inpatient care, in particular, hysterectomy. CONCLUSION: Uterine fibroid tumors consume a significant amount of health care resources in the United States.
OBJECTIVE: The purpose of this study was to quantify the total direct cost to the US health care system for the management of uterine leiomyomas. STUDY DESIGN: We used Center for Disease Control heath care databases for estimates of inpatient care, ambulatory care, and outpatient care of leiomyomas. With International Classification of Diseases-9 codes for fibroid tumors and fibroid-related conditions, all fibroid-related care was identified in each database. Inpatient and ambulatory surgical cases were stratified by surgical procedure, and outpatient clinical cases were categorized by type of visit and health care provider. With the use of Medicare's RBRVU reimbursement rates for 2000 as a proxy for the cost of physician services and Medicare diagnostic-related group reimbursement as a proxy for facility costs, the total direct cost to the US health care system for the care of fibroid tumors was estimated. RESULTS: Total direct cost to treat uterine fibroid tumors was estimated at 2,151,484,847 dollars. Most of the cost was due to inpatient care, in particular, hysterectomy. CONCLUSION: Uterine fibroid tumors consume a significant amount of health care resources in the United States.
Authors: Lauren A Wise; Rose G Radin; Julie R Palmer; Shiriki K Kumanyika; Deborah A Boggs; Lynn Rosenberg Journal: Am J Clin Nutr Date: 2011-11-09 Impact factor: 7.045
Authors: Zehra Ordulu; Paola Dal Cin; Wilson W S Chong; Kwong Wai Choy; Charles Lee; Michael G Muto; Bradley J Quade; Cynthia C Morton Journal: Genes Chromosomes Cancer Date: 2010-12 Impact factor: 5.006
Authors: Desireé M McCarthy-Keith; Minnie Malik; Joy Britten; James Segars; William H Catherino Journal: Fertil Steril Date: 2011-04-15 Impact factor: 7.329
Authors: Kellen L Meadows; Danica M K Andrews; Zongli Xu; Gleta K Carswell; Shannon K Laughlin; Donna D Baird; Jack A Taylor Journal: Exp Mol Pathol Date: 2011-04-08 Impact factor: 3.362
Authors: Erica E Marsh; Geraldine E Ekpo; Eden R Cardozo; Maureen Brocks; Tanaka Dune; Leeber S Cohen Journal: Fertil Steril Date: 2013-03-15 Impact factor: 7.329
Authors: Lauren A Wise; Rose G Radin; Julie R Palmer; Shiriki K Kumanyika; Lynn Rosenberg Journal: Am J Epidemiol Date: 2009-12-02 Impact factor: 4.897
Authors: Jennelle C Hodge; Peter J Park; Jonathan M Dreyfuss; Iman Assil-Kishawi; Priya Somasundaram; Luwam G Semere; Bradley J Quade; Allison M Lynch; Elizabeth A Stewart; Cynthia C Morton Journal: Genes Chromosomes Cancer Date: 2009-10 Impact factor: 5.006
Authors: David Shveiky; Cheryl B Iglesia; Danielle D Antosh; Bela I Kudish; Joanna Peterson; Chun-Chih Huang; Chun-Chin Huang; James B Spies Journal: Int Urogynecol J Date: 2012-12-18 Impact factor: 2.894